A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation

Clinical trial NCT03942263 · COMPLETED

Trial details

NCT number: NCT03942263
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Hodgkin Disease Lymphoma, Large-cell, Anaplastic

Start date: 2019-05-31
Primary completion: 2022-12-08
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.